HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome

被引:0
|
作者
Nakaya, Yosuke [1 ]
Koh, Hideo [2 ]
Konuma, Takaaki [3 ]
Shimomura, Yoshimitsu [4 ,5 ]
Ishiyama, Ken [6 ]
Itonaga, Hidehiro [7 ]
Hino, Masayuki [1 ]
Doki, Noriko [8 ]
Nishida, Tetsuya [9 ]
Ohigashi, Hiroyuki [10 ]
Matsuoka, Ken-ichi [11 ]
Kanda, Yoshinobu [12 ]
Maruyama, Yumiko [13 ]
Sawa, Masashi [14 ]
Eto, Tetsuya [15 ]
Hiramoto, Nobuhiro [4 ]
Fukuda, Takahiro [16 ]
Atsuta, Yoshiko [17 ,18 ]
Nakamae, Hirohisa [1 ]
机构
[1] Osaka Metropolitan Univ, Grad Sch Med, Dept Hematol, Osaka, Japan
[2] Osaka Metropolitan Univ, Grad Sch Med, Dept Prevent Med & Environm Hlth, Osaka, Japan
[3] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan
[4] Kobe City Med Ctr Gen Hosp, Dept Hematol, Kobe, Japan
[5] Osaka Univ, Grad Sch Med, Dept Environm Med & Populat Sci, Suita, Japan
[6] Natl Ctr Global Hlth & Med, Dept Hematol, Tokyo, Japan
[7] Nagasaki Univ Hosp, Transfus & Cell Therapy Unit, Nagasaki, Japan
[8] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan
[9] Nagoya Daiichi Hosp, Japanese Red Cross Aichi Med Ctr, Dept Hematol, Nagoya, Japan
[10] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Japan
[11] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan
[12] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan
[13] Univ Tsukuba Hosp, Dept Hematol, Tsukuba, Japan
[14] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Japan
[15] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan
[16] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[17] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Japan
[18] Aichi Med Univ, Sch Med, Dept Registry Sci Transplant & Cellular Therapy, Nagakute, Japan
来源
TRANSPLANTATION AND CELLULAR THERAPY | 2024年 / 30卷 / 03期
关键词
Myelodysplastic; syndrome; Peripheral blood stem; cell transplantation; Haploidentical donor; Matched unrelated donor; Post-transplantation; cyclophosphamide; BONE-MARROW-TRANSPLANTATION; WORLD-HEALTH-ORGANIZATION; MYELOID NEOPLASMS; ACUTE-LEUKEMIA; TRUMP DATA; IMPACT; CLASSIFICATION; DISPARITY; SURVIVAL; REVISION;
D O I
10.1016/j.jtct.2023.10.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Allogeneic hematopoietic cell transplantation (allo-HCT) is the sole curative therapy for myelodysplastic syndrome (MDS). In the absence of an HLA-matched sibling donor, an HLA-matched unrelated donor (MUD) is considered the leading candidate. However, in recent decades, the alternative donor pool has been extended to HLA-haploidentical donors, especially with the development of graft -versus -host disease (GVHD) prophylaxis using post -transplantation cyclophosphamide (PTCy). Comparative data for haploidentical
引用
收藏
页码:316.e1 / 316.e12
页数:12
相关论文
共 50 条
  • [41] HLA-haploidentical bone marrow transplantation with high-dose post-transplantation cyclophosphamide (Cy)
    Busca, A.
    Bruno, B.
    Giaccone, L.
    Festuccia, M.
    Testa, F.
    Allione, B.
    D'Ardia, S.
    Dellacasa, C.
    Pecoraro, C.
    Marmont, F.
    Falda, M.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S185 - S185
  • [42] Low Incidence of Chronic GVHD after HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post Transplantation Cyclophosphamide in Older Patients
    Devillier, Raynier
    Granata, Angela
    Fuerst, Sabine
    Harbi, Samia
    Faucher, Catherine
    Weiller, Pierre Jean
    Chabannon, Christian
    Castagna, Luca
    Blaise, Didier
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S369 - S370
  • [43] Griscell-Syndrome: succesful HLA-haploidentical peripheral blood stem cell transplantation
    Schuster, F
    Stachel, D
    Schmid, I
    Baumeister, F
    Albert, M
    Graubner, U
    Weiss, M
    Belohradsky, B
    Haas, R
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S196 - S196
  • [44] Posttransplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation
    Mielcarek, Marco
    Furlong, Terrence
    O'Donnell, Paul V.
    Storer, Barry E.
    Storb, Rainer F.
    Carpenter, Paul A.
    Martin, Paul J.
    [J]. BLOOD, 2014, 124 (21)
  • [45] Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia
    Frédéric Baron
    Myriam Labopin
    Johanna Tischer
    Fabio Ciceri
    Anna Maria Raiola
    Didier Blaise
    Simona Sica
    Jan Vydra
    Renato Fanin
    Jose Luis Diez-Martin
    Claude Eric Bulabois
    Friedrich Stölzel
    Alessandro Busca
    Pavel Jindra
    Yener Koc
    Patrice Chevallier
    Edouard Forcade
    Wolf Rösler
    Jakob Passweg
    Alexander Kulagin
    Angelo Michele Carella
    Celestine Simand
    Ali Bazarbachi
    Pietro Pioltelli
    Arnon Nagler
    Mohamad Mohty
    [J]. Bone Marrow Transplantation, 2022, 57 : 1657 - 1663
  • [46] Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide
    DeZern, Amy E.
    Elmariah, Hany
    Zahurak, Marianna
    Rosner, Gary L.
    Gladstone, Douglas E.
    Ali, Syed Abbas
    Huff, Carol Ann
    Swinnen, Lode J.
    Imus, Phil
    Borrello, Ivan
    Wagner-Johnston, Nina D.
    Ambinder, Richard F.
    Brodsky, Robert A.
    Cooke, Kenneth
    Luznik, Leo
    Fuchs, Ephraim J.
    Bolanos-Meade, Javier
    Jones, Richard J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (11) : 2075 - 2081
  • [47] Immune Reconstitution after HLA-Haploidentical and HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide
    Cengiz-Seval, G.
    Vulic, A.
    McCurdy, S.
    Kanakry, C.
    Varadhan, R.
    Symons, H.
    Luznik, L.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S239 - S240
  • [48] HLA-haploidentical peripheral blood stem cell transplantation in children with hematological malignancies
    Müller, SM
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S90 - S90
  • [49] Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
    Kasamon, Yvette L.
    Bolanos-Meade, Javier
    Prince, Gabrielle T.
    Tsai, Hua-Ling
    McCurdy, Shannon R.
    Kanakry, Jennifer A.
    Rosner, Gary L.
    Brodsky, Robert A.
    Perica, Karlo
    Smith, B. Douglas
    Gladstone, Douglas E.
    Swinnen, Lode J.
    Showel, Margaret M.
    Matsui, William H.
    Huff, Carol Ann
    Borrello, Ivan
    Pratz, Keith W.
    McDevitt, Michael A.
    Gojo, Ivana
    Dezern, Amy E.
    Shanbhag, Satish
    Levis, Mark J.
    Luznik, Leo
    Ambinder, Richard F.
    Fuchs, Ephraim J.
    Jones, Richard J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28) : 3152 - +
  • [50] Post-transplant cyclophosphamide versus antithymocyte-globulin in HLA-matched unrelated and haploidentical transplantation for hematologic malignancies
    Lee, Myung Won
    Song, Ik Chan
    Choi, Yoon Seok
    Lee, Su Jin
    Cho, Seon Hui
    Jo, Deog Yeon
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 326 - 327